Pharmacogenetics of methotrexate in acute lymphoblastic leukaemia: why still at the bench level? Sunitha KodidelaPradhan Suresh ChandraBiswajit Dubashi Review Article 27 December 2013 Pages: 253 - 260
Almost a tragedy: severe methotrexate toxicity in a hemodialysis patient treated for ectopic pregnancy Nadav WillnerShimon StorchElad Schiff Special Article 26 November 2013 Pages: 261 - 263
Improved accuracy of anticoagulant dose prediction using a pharmacogenetic and artificial neural network-based method Hussain A. Isma’eelGeorge E. SakrImad H. Elhajj Pharmacogenetics 03 December 2013 Pages: 265 - 273
HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons Syndrome/Toxic Epidermal Necrolysis susceptibility in a population from Mozambique Paola BorgianiDavide Di FuscoCinzia Ciccacci Pharmacogenetics 10 December 2013 Pages: 275 - 278
Effect of moderate liver impairment on the pharmacokinetics of opicapone José Francisco RochaAna SantosPatrício Soares-da-Silva Pharmacokinetics and Disposition 24 November 2013 Pages: 279 - 286
Effects of ponesimod, a selective S1P1 receptor modulator, on the pharmacokinetics of a hormonal combination contraceptive Maribel ReyesPatrick BrossardJasper Dingemanse Pharmacokinetics and Disposition 22 December 2013 Pages: 287 - 293
Persistence of antihypertensive drug use in German primary care: a follow-up study based on pharmacy claims data Thomas GrimmsmannWolfgang Himmel Pharmacoepidemiology and Prescription 26 November 2013 Pages: 295 - 301
Compliance with quality prescribing indicators linked to financial incentives: what about not incentivized indicators?: an observational study R. Fernández UrrusunoP. Pérez PérezB. Pascual de la Pisa Pharmacoepidemiology and Prescription 03 December 2013 Pages: 303 - 311
Checklist for standardized reporting of drug–drug interaction management guidelines Annemieke Floor-SchreuderingArjen F. J. GeertsPeter A. G. M. De Smet Pharmacoepidemiology and Prescription 05 December 2013 Pages: 313 - 318
Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults Juha PuustinenRitva LähteenmäkiSirkka-Liisa Kivelä Pharmacoepidemiology and Prescription 12 December 2013 Pages: 319 - 329
Antibiotic and anti-asthmatic drug prescriptions in Italy: geographic patterns and socio-economic determinants at the district level Daniele PiovaniAntonio Clavennaon behalf of the Interregional Italian Drug Utilisation Group Pharmacoepidemiology and Prescription 06 December 2013 Pages: 331 - 337
Drug-induced agranulocytosis in the Berlin case–control surveillance study Matthias HuberFrank AndersohnEdeltraut Garbe Pharmacoepidemiology and Prescription 03 December 2013 Pages: 339 - 345
The quality of outpatient antimicrobial prescribing: a comparison between two areas of northern and southern Europe Sara MaloLars BjerrumMaría José Rabanaque-Hernández Pharmacoepidemiology and Prescription 10 December 2013 Pages: 347 - 353
Fetal safety of erythromycin. An update of Swedish data Bengt KällénBengt R. Danielsson Pharmacoepidemiology and Prescription 20 December 2013 Pages: 355 - 360
Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission Consuelo PedrósBeatriz QuintanaJosep Maria Arnau Pharmacoepidemiology and Prescription 21 December 2013 Pages: 361 - 367
On the possible interaction between vaccines and drugs Paolo PellegrinoCarla CarnovaleSonia Radice Letter to the Editors 05 December 2013 Pages: 369 - 371
Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis – insights into possible drug mechanism Victor VoonLavanya SaivaDavid Keane Letter to the Editors 06 December 2013 Pages: 373 - 375
Pharmacokinetic changes after placement of a transjugular intrahepatic portosystemic shunt Sabrina De WinterSandra VerelstIsabel Spriet Letter to the Editors 19 December 2013 Pages: 377 - 378